Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium-Reference-Cited by-同舟云学术

Initial in vivo testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium

Published:2020-08-17 Issue:1 Volume:38 Page:8-13
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Nevil Grace¹,Roth Michael¹,Gill Jonathan¹,Zhang Wendong¹,Teicher Beverly²,Erickson Stephen W.³,Gatto Gregory³,Smith Malcom²,Kolb E. Anders⁴,Gorlick Richard¹

Affiliation:

1. Division of Pediatric Oncology, MD Anderson Children’s Cancer Hospital, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

2. National Cancer Institute, Bethesda, maryland, USA

3. RTI International, Research Triangle Park, North Carolina, USA

4. Division of Pediatric Hematology/Oncology, A.I. duPont Hospital for Children, Wilmington, Delaware, USA

Funder

National Cancer Institute, Swim Across America, and the Foster Foundation

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link